Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-05 · accession 0001231589-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-03-05 | 2026-03-05 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $483.15 | -8,300 | 40.2K | -17% | -$4.01M |
| DT | 2026-03-05 | 2026-03-05 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 45.1K | +23% | +$1.21M |
| DT | 2026-03-05 | 2026-03-05 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -8,300 | 33.5K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-05 | S | D | 1,602 | $480.22 | 43,174 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $479.82 to $480.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-03-05 | S | D | 368 | $479.43 | 44,776 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $478.82 to $479.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-03-05 | M | A | 8,300 | $146.03 | 45,144 | D | — | — | (F2) Includes 63 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan. |
| 4 | Common | Common Stock | 2026-03-05 | S | D | 1,006 | $485.32 | 37,787 | D | — | — | (F9) This transaction was executed in multiple trades at prices ranging from $485.10 to $485.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-03-05 | S | D | 200 | $487.65 | 36,844 | D | — | — | (F11) This transaction was executed in multiple trades at prices ranging from $487.475 to $487.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-03-05 | S | D | 743 | $486.52 | 37,044 | D | — | — | (F10) This transaction was executed in multiple trades at prices ranging from $486.41 to $486.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-03-05 | S | D | 1,177 | $482.68 | 41,277 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $482.025 to $482.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-03-05 | S | D | 720 | $481.33 | 42,454 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $481.02 to $481.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-03-05 | S | D | 1,398 | $484.55 | 38,793 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $484.07 to $484.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2026-03-05 | S | D | 1,086 | $483.54 | 40,191 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $483.07 to $484.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Derivative | Stock Option | 2026-03-05 | M | D | 8,300 | $0.00 | 33,500 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,300 Common Stock |